Results of Operations

Phathom Pharmaceuticals, Inc. reported its first quarter 2026 financial results on April 30, 2026, announcing a significant year-over-year increase in net revenues and providing updated financial guidance for the full year 2026. The company also provided an update on its VOQUEZNA commercial progress and clinical trial enrollment.